386 related articles for article (PubMed ID: 33705943)
1. Nano formulated Resveratrol inhibits metastasis and angiogenesis by reducing inflammatory cytokines in oral cancer cells by targeting tumor associated macrophages.
Pradhan R; Chatterjee S; Hembram KC; Sethy C; Mandal M; Kundu CN
J Nutr Biochem; 2021 Jun; 92():108624. PubMed ID: 33705943
[TBL] [Abstract][Full Text] [Related]
2. Nano formulated Resveratrol inhibits PD-L1 in oral cancer cells by deregulating the association between tumor associated macrophages and cancer associated fibroblasts through IL-6/JAK2/STAT3 signaling axis.
Pradhan R; Paul S; Acharya SS; Sinha S; Dash SR; Kundu CN
J Nutr Biochem; 2024 Mar; 125():109568. PubMed ID: 38185347
[TBL] [Abstract][Full Text] [Related]
3. Resveratrol nanoparticle attenuates metastasis and angiogenesis by deregulating inflammatory cytokines through inhibition of CAFs in oral cancer by CXCL-12/IL-6-dependent pathway.
Pradhan R; Paul S; Das B; Sinha S; Dash SR; Mandal M; Kundu CN
J Nutr Biochem; 2023 Mar; 113():109257. PubMed ID: 36572069
[TBL] [Abstract][Full Text] [Related]
4. Metallic gold and bioactive quinacrine hybrid nanoparticles inhibit oral cancer stem cell and angiogenesis by deregulating inflammatory cytokines in p53 dependent manner.
Satapathy SR; Nayak A; Siddharth S; Das S; Nayak D; Kundu CN
Nanomedicine; 2018 Apr; 14(3):883-896. PubMed ID: 29366881
[TBL] [Abstract][Full Text] [Related]
5. Protein-Bound Polysaccharides from
Jędrzejewski T; Pawlikowska M; Sobocińska J; Wrotek S
Cell Physiol Biochem; 2020 Jun; 54(4):615-628. PubMed ID: 32559360
[TBL] [Abstract][Full Text] [Related]
6. Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes.
Han S; Wang W; Wang S; Yang T; Zhang G; Wang D; Ju R; Lu Y; Wang H; Wang L
Theranostics; 2021; 11(6):2892-2916. PubMed ID: 33456579
[No Abstract] [Full Text] [Related]
7. Anemoside A3 activates TLR4-dependent M1-phenotype macrophage polarization to represses breast tumor growth and angiogenesis.
Yin L; Fan Z; Liu P; Chen L; Guan Z; Liu Y; Luo Y
Toxicol Appl Pharmacol; 2021 Dec; 432():115755. PubMed ID: 34673087
[TBL] [Abstract][Full Text] [Related]
8. Quinacrine inhibits HIF-1α/VEGF-A mediated angiogenesis by disrupting the interaction between cMET and ABCG2 in patient-derived breast cancer stem cells.
Das B; Dash SR; Patel H; Sinha S; Bhal S; Paul S; Das C; Pradhan R; Ahmed I; Goutam K; Kundu CN
Phytomedicine; 2023 Aug; 117():154914. PubMed ID: 37321076
[TBL] [Abstract][Full Text] [Related]
9. Phloretin suppresses metastasis by targeting protease and inhibits cancer stemness and angiogenesis in human cervical cancer cells.
Hsiao YH; Hsieh MJ; Yang SF; Chen SP; Tsai WC; Chen PN
Phytomedicine; 2019 Sep; 62():152964. PubMed ID: 31153059
[TBL] [Abstract][Full Text] [Related]
10. Tumor-associated macrophages derived from cancer stem cells.
Osman A; Oze M; Afify SM; Hassan G; El-Ghlban S; Nawara HM; Fu X; Zahra MH; Seno A; Winer I; Salomon DS; Seno M
Acta Histochem; 2020 Dec; 122(8):151628. PubMed ID: 32992123
[TBL] [Abstract][Full Text] [Related]
11. Elevated S100A9 expression in tumor stroma functions as an early recurrence marker for early-stage oral cancer patients through increased tumor cell invasion, angiogenesis, macrophage recruitment and interleukin-6 production.
Fang WY; Chen YW; Hsiao JR; Liu CS; Kuo YZ; Wang YC; Chang KC; Tsai ST; Chang MZ; Lin SH; Wu LW
Oncotarget; 2015 Sep; 6(29):28401-24. PubMed ID: 26315114
[TBL] [Abstract][Full Text] [Related]
12. The mechanism of lncRNA-CRNDE in regulating tumour-associated macrophage M2 polarization and promoting tumour angiogenesis.
Han C; Yang Y; Sheng Y; Wang J; Li W; Zhou X; Guo L
J Cell Mol Med; 2021 May; 25(9):4235-4247. PubMed ID: 33742511
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of nitric oxide and inflammatory cytokines in LPS-stimulated murine macrophages by resveratrol, a potent proteasome inhibitor.
Qureshi AA; Guan XQ; Reis JC; Papasian CJ; Jabre S; Morrison DC; Qureshi N
Lipids Health Dis; 2012 Jul; 11():76. PubMed ID: 22698256
[TBL] [Abstract][Full Text] [Related]
14. Exosome-mediated miR-33 transfer induces M1 polarization in mouse macrophages and exerts antitumor effect in 4T1 breast cancer cell line.
Moradi-Chaleshtori M; Bandehpour M; Heidari N; Mohammadi-Yeganeh S; Mahmoud Hashemi S
Int Immunopharmacol; 2021 Jan; 90():107198. PubMed ID: 33249048
[TBL] [Abstract][Full Text] [Related]
15. Resveratrol attenuates TNBC lung metastasis by down-regulating PD-1 expression on pulmonary T cells and converting macrophages to M1 phenotype in a murine tumor model.
Han X; Zhao N; Zhu W; Wang J; Liu B; Teng Y
Cell Immunol; 2021 Oct; 368():104423. PubMed ID: 34399171
[TBL] [Abstract][Full Text] [Related]
16. Tumor microenvironment and Oral Squamous Cell Carcinoma: A crosstalk between the inflammatory state and tumor cell migration.
Alves A; Diel L; Ramos G; Pinto A; Bernardi L; Yates J; Lamers M
Oral Oncol; 2021 Jan; 112():105038. PubMed ID: 33129055
[TBL] [Abstract][Full Text] [Related]
17. CD44 Sorted Cells Have an Augmented Potential for Proliferation, Epithelial-Mesenchymal Transition, Stemness, and a Predominantly Inflammatory Cytokine and Angiogenic Secretome.
Patil S
Curr Issues Mol Biol; 2021 Jun; 43(1):423-433. PubMed ID: 34205649
[TBL] [Abstract][Full Text] [Related]
18. Anti-cancer effect of genistein in oral squamous cell carcinoma with respect to angiogenesis and in vitro invasion.
Myoung H; Hong SP; Yun PY; Lee JH; Kim MJ
Cancer Sci; 2003 Feb; 94(2):215-20. PubMed ID: 12708500
[TBL] [Abstract][Full Text] [Related]
19. Pristimerin Inhibits Prostate Cancer Bone Metastasis by Targeting PC-3 Stem Cell Characteristics and VEGF-Induced Vasculogenesis of BM-EPCs.
Huang S; He P; Peng X; Li J; Xu D; Tang Y
Cell Physiol Biochem; 2015; 37(1):253-68. PubMed ID: 26302893
[TBL] [Abstract][Full Text] [Related]
20. Genistein inhibits stemness of SKOV3 cells induced by macrophages co-cultured with ovarian cancer stem-like cells through IL-8/STAT3 axis.
Ning Y; Feng W; Cao X; Ren K; Quan M; Chen A; Xu C; Qiu Y; Cao J; Li X; Luo X
J Exp Clin Cancer Res; 2019 Jan; 38(1):19. PubMed ID: 30646963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
